REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Astrazeneca Lietuva (Lithuania)

Main Activities: Research and Development in the Social Sciences and Humanities | Marketing Research and Public Opinion Polling
Secondary Activities: Advertising Agencies
Full name: UAB Astrazeneca Lietuva Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Astrazeneca Lietuva is based in Lithuania, with the head office in Vilnius. It operates in the Research and Development in the Social Sciences and Humanities industry. It was first established on February 18, 2005. It currently has a total number of 46 (2025) employees. From the latest financial highlights, UAB Astrazeneca Lietuva reported a net sales revenue increase of 33.18% in 2024. The net profit margin of UAB Astrazeneca Lietuva decreased by 0.1% in 2024.

Headquarters
Spaudos g. 6-1
Vilnius; Vilnius county; Postal Code: LT-05132

Contact Details: Purchase the UAB Astrazeneca Lietuva report to view the information.

Basic Information
Total Employees:
Purchase the UAB Astrazeneca Lietuva report to view the information.
Registered Capital:
Purchase the UAB Astrazeneca Lietuva report to view the information.
Financial Auditors:
Purchase the UAB Astrazeneca Lietuva report to view the information.
Incorporation Date:
February 18, 2005
Key Executives
Purchase this report to view the information.
Member of the Management Board
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after UAB Astrazeneca Lietuva report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
33.18%
Total operating revenue
33.18%
Net Profit/Loss for the Period
30.11%
Total Equity
14.64%
Net Profit Margin
-0.1%
Return on Equity (ROE)
1.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?